UK markets open in 2 hours 59 minutes
NIKKEI 225
38,698.50 -248.43 (-0.64%) HANG SENG
19,250.29 +29.67 (+0.15%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,418.30 -7.60 (-0.31%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,013.45 -1,061.14 (-1.89%)
Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 142.01M |
| Enterprise value | 179.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.31 |
| Price/book (mrq) | 2.06 |
| Enterprise value/revenue | 1.68 |
| Enterprise value/EBITDA | 82.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.46 |
| 52-week change 3 | -42.43% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 6.2000 |
| 52-week low 3 | 3.2500 |
| 50-day moving average 3 | 3.9646 |
| 200-day moving average 3 | 4.3419 |
Share statistics
| Avg vol (3-month) 3 | 91.43k |
| Avg vol (10-day) 3 | 74.85k |
| Shares outstanding 5 | 43.43M |
| Implied shares outstanding 6 | 43.43M |
| Float 8 | 35.21M |
| % held by insiders 1 | 7.28% |
| % held by institutions 1 | 77.02% |
| Shares short (30 Apr 2024) 4 | 681.18k |
| Short ratio (30 Apr 2024) 4 | 6.56 |
| Short % of float (30 Apr 2024) 4 | 1.69% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.57% |
| Shares short (prior month 28 Mar 2024) 4 | 636.65k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1319:1000 |
| Last split date 3 | 04 Nov 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -8.18% |
| Operating margin (ttm) | -9.30% |
Management effectiveness
| Return on assets (ttm) | -0.69% |
| Return on equity (ttm) | -12.20% |
Income statement
| Revenue (ttm) | 106.79M |
| Revenue per share (ttm) | 2.50 |
| Quarterly revenue growth (yoy) | -18.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 5.53M |
| Net income avi to common (ttm) | -8.73M |
| Diluted EPS (ttm) | -0.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.25M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 41.36M |
| Total debt/equity (mrq) | 60.11% |
| Current ratio (mrq) | 1.88 |
| Book value per share (mrq) | 1.59 |
Cash flow statement
| Operating cash flow (ttm) | 13.62M |
| Levered free cash flow (ttm) | 13.77M |
© 2024 Yahoo. All rights reserved.